Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

The Dark Secrets of Johnson & Johnson.” Gardiner Harris, a former pharmaceutical reporter for The New York Times and a reporter for The Wall Street Journal, effectively explains the legal battles ...

Mar Vista U.S. Quality Select Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its Q1 2025 investor ...

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...

Wall Street analysts expect Johnson & Johnson (JNJ) to post quarterly earnings of $2.57 per share in its upcoming report, which indicates a year-over-year decline of 5.2%. Revenues are expected to ...

National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, ...

Corporate America is counting the cost of Donald Trump’s trade war, with executives warning of escalating expenditures, gummed-up supply chains and a hit to the world’s largest economy.

Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs.

Copy trade alerts from Matt Maley—a Wall Street veteran who consistently ... 2.3% or 4.2 operationally to $13.90 billion. Also Read: Johnson & Johnson, Protagonist Tout Positive Results For ...

The US Customs and Border Protection announced a tariff exclusion for some electronics on Friday, only for US Commerce ...